The effect of thrombin on the density distribution of blood platelets: detection of activated platelets in the circulation.
The buoyant density of human platelets is decreased after they have been aggregated and induced to secrete their granule content by thrombin. This change in density was detected by discontinuous density gradient centrifugation using arabinogalactan (Stractan) solutions. The density decrease was dependent on the thrombin concentration and paralleled the extent of serotonin and beta-thromboglobulin secretion. The degranulated platelets maintained their integrity, and many of their functional properties. Mixtures of degranulated platelets and normal platelets could be resolved by Stractan gradient centrifugation and the number of degranulated platelets quantitated. Using this method, increased levels of less dense platelets were shown to occur after cardiopulmonary bypass. Assay of changes in platelet density by Stractan gradient centrifugation is a useful method for detection of activated platelets in vitro and in vivo.
D000225:Adenine / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002315:Cardiopulmonary Bypass; D002469:Cell Separation / Q000379:methods; D002499:Centrifugation, Density Gradient; D006801:Humans; D066298:In Vitro Techniques; D010976:Platelet Count; D012701:Serotonin / Q000378:metabolism; D013917:Thrombin / Q000494:pharmacology*; D001620:beta-Thromboglobulin / Q000097:blood
D001620:beta-Thromboglobulin; D012701:Serotonin; D013917:Thrombin; D000225:Adenine